PreprintCited by 45Advanced biosensing and bioanalysis techniquesRNA and protein synthesis mechanismsDNA and Biological Computing

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Generative and interpretable machine learning for aptamer design and analysis of in vitro sequence selection

Open access
Di Gioacchino, Andrea, Procyk, Jonah, Molari, Marco, Schreck, John S., Zhou, Yu, Liu, Yan, Monasson, Rémi, Cocco, Simona, Šulc, Petr·2022·PLoS Computational Biology

Preprint — published as 10.1371/journal.pcbi.1010561 · Paper page

Abstract

Selection protocols such as SELEX, where molecules are selected over multiple rounds for their ability to bind to a target molecule of interest, are popular methods for obtaining binders for diagnostic and therapeutic purposes. With the increasing amount of such high-throughput experimental data available, machine learning techniques have become increasingly popular for molecular datasets analysis. Here, we show that Restricted Boltzmann Machines (RBMs), a two-layer neural network architecture, can successfully be trained on sequence ensembles from SELEX experiments for thrombin aptamers, and used to estimate the fitness of the sequences obtained through the experimental protocol. As a direct consequence, we show that trained RBMs can be exploited to classify as well as generate novel molecules. To confirm our findings, we experimentally verify the generated sequences from RBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.03.12.484094

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. 2015, Fastaptamer: a bioinformatic toolkit for high-throughput sequence analysis of combinatorial selections, Molecular Therapy-Nucleic Acids, 4, e230, 10.1038/mtna.2015.4 · DOI
  2. 10.1093/nar/gkv416 · DOI
  3. P. Bannigan , M. Aldeghi , Z. Bao , F. Häse , A. Aspuru-Guzik , and C. Allen . Machine learning directed drug formulation development. Advanced Drug Delivery Reviews, 2021. · DOI
  4. 2022, Modeling sequence-space exploration and emergence of epistatic signals in protein evolution, Molecular biology and evolution, 39, msab321, 10.1093/molbev/msab321 · DOI · Paper page
  5. 2021, RBM-MHC: A semisupervised machine-learning method for sample-specific prediction of antigen presentation by hla-i alleles, Cell systems, 12, 195, 10.1016/j.cels.2020.11.005 · DOI
  6. 2021, Deep diversification of an aav capsid protein by machine learning, Nature Biotechnology, 39, 691, 10.1038/s41587-020-00793-4 · DOI
  7. 2018, Systematic evaluation of cell-selex enriched aptamers binding to breast cancer cells, Biochimie, 145, 53, 10.1016/j.biochi.2017.10.007 · DOI
  8. 2018, Inverse statistical physics of protein sequences: a key issues review, Reports on Progress in Physics, 81, 032601, 10.1088/1361-6633/aa9965 · DOI
  9. 10.1093/nar/gkv932 · DOI
  10. 2018, Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes, Nature communications, 9, 1
  11. 2020, Machine learning models for drug–target interactions: current knowledge and future directions, Drug Discovery Today, 25, 748, 10.1016/j.drudis.2020.03.003 · DOI
  12. 10.1038/346818a0 · DOI
  13. 2020, Chemical modification of aptamers for increased binding affinity in diagnostic applications: Current status and future prospects, International Journal of Molecular Sciences, 21, 4522, 10.3390/ijms21124522 · DOI
  14. 2014, Antibody phage display: technique and applications, The Journal of investigative dermatology, 134, e17
  15. 1985, Limits of adaptation: The evolution of selective neutrality, Genetics, 111, 655, 10.1093/genetics/111.3.655 · DOI
  16. 10.1162/089976602760128018 · DOI · Paper page
  17. 10.1093/bioinformatics/bts210 · DOI
  18. 2020, Adapt identifies an escrt complex composition that discriminates vcap from lncap prostate cancer cell exosomes, Nucleic acids research, 48, 4013, 10.1093/nar/gkaa034 · DOI
  19. 10.1093/bioinformatics/btu348 · DOI
  20. 2019, Why do g-quadruplexes dimerize through the 5’-ends? driving forces for g4 dna dimerization examined in atomic detail, PLoS computational biology, 15, e1007383, 10.1371/journal.pcbi.1007383 · DOI
  21. P. K. Koo , P. Anand , S. B. Paul , and S. R. Eddy . Inferring sequence-structure preferences of RNA-binding proteins with convolutional residual networks. BioRxiv, page 418459, 2018. · DOI
  22. 2020, Deep learning for inferring transcription factor binding sites, Current opinion in systems biology, 19, 16, 10.1016/j.coisb.2020.04.001 · DOI
  23. 10.1016/S0958-1669(02)00380-4 · DOI
  24. 2015, Selective aptamer-based control of intraneuronal signaling, Angewandte Chemie, 127, 5459, 10.1002/ange.201409597 · DOI
  25. 2017, Integrated analysis of rna-binding protein complexes using in vitro selection and high-throughput sequencing and sequence specificity landscapes (seqrs), Methods, 118, 171
  26. 2009, From selection to caged aptamers: identification of light-dependent ssdna aptamers targeting cytohesin, Bioorganic & medicinal chemistry letters, 19, 6561, 10.1016/j.bmcl.2009.10.032 · DOI
  27. 10.1073/pnas.1111471108 · DOI · Paper page
  28. 10.1103/RevModPhys.83.1283 · DOI
  29. A. D. Ortega , V. Takhaveev , S. R. Vedelaar , Y. Long , N. Mestre-Farras , D. Incarnato , F. Ersoy , L. F. Olsen , G. Mayer , and M. Heinemann . A synthetic rna-based biosensor for fructose-1, 6-bisphosphate that reports glycolytic flux. Cell Chemical Biology, 2021. · DOI
  30. 1993, The structure of alpha-thrombin inhibited by a 15-mer single-stranded dna aptamer, Journal of Biological Chemistry, 268, 17651, 10.1016/S0021-9258(17)46749-4 · DOI
  31. 2018, Systematic evaluation of error rates and causes in short samples in next-generation sequencing, Scientific reports, 8, 1
  32. 10.1093/nar/gkx540 · DOI
  33. 10.1021/jacs.8b13298 · DOI
  34. 10.1007/s00253-005-0193-5 · DOI
  35. 2020, Aptamer-mediated reversible transactivation of gene expression by light, Angewandte Chemie, 132, 22600, 10.1002/ange.202009240 · DOI
  36. 2019, A receptor-guided design strategy for ligand identification, Angewandte Chemie International Edition, 58, 10752, 10.1002/anie.201903479 · DOI
  37. 2021, Barriers and dynamical paths in alternating gibbs sampling of restricted boltzmann machines, Physical Review E, 104, 034109, 10.1103/PhysRevE.104.034109 · DOI
  38. 10.1126/science.aba3304 · DOI · Paper page
  39. 2021, A sars-cov-2 spike binding dna aptamer that inhibits pseudovirus infection by an rbd-independent mechanism, Angewandte Chemie International Edition, 60, 10279, 10.1002/anie.202100316 · DOI
  40. 2017, Activation of the glms ribozyme confers bacterial growth inhibition, Chembiochem, 18, 435, 10.1002/cbic.201600491 · DOI
  41. 2021, Amala: Analysis of directed evolution experiments via annealed mutational approximated landscape, International journal of molecular sciences, 22, 10908, 10.3390/ijms222010908 · DOI
  42. 2020, Aptamers against live targets: is in vivo selex finally coming to the edge?, Molecular Therapy-Nucleic Acids, 21, 192, 10.1016/j.omtn.2020.05.025 · DOI
  43. 2019, A sequential multidimensional analysis algorithm for aptamer identification based on structure analysis and machine learning, Analytical chemistry, 92, 3307
  44. T. Tieleman . Training restricted boltzmann machines using approximations to the likelihood gradient. In Proceedings of the 25th International Conference on Machine Learning, ICML ’08, page 1064–1071, New York, NY, USA, 2008. Association for Computing Machinery. · DOI
  45. 10.1126/science.abe5650 · DOI
  46. 2019, Learning protein constitutive motifs from sequence data, eLife, 8, e39397, 10.7554/eLife.39397 · DOI
  47. 2017, Emergence of compositional representations in restricted boltzmann machines, Phys. Rev. Lett, 118, 138301, 10.1103/PhysRevLett.118.138301 · DOI
  48. 10.1126/science.2200121 · DOI
  49. A. Wagner . Robustness and evolvability in living systems. Princeton university press, 2013. · DOI
  50. 2014, Cell-type-specific, aptamer-functionalized agents for targeted disease therapy, Molecular Therapy-Nucleic Acids, 3, e169, 10.1038/mtna.2014.21 · DOI
  51. 2018, Global pairwise rna interaction landscapes reveal core features of protein recognition, Nature communications, 9, 1
  52. 2017, Exploring the mutational robustness of nucleic acids by searching genotype neighborhoods in sequence space, The Journal of Physical Chemistry Letters, 8, 407, 10.1021/acs.jpclett.6b02769 · DOI
  53. 2015, Searching the sequence space for potent aptamers using SELEX in silico, Journal of Chemical Theory and Computation, 11, 5939, 10.1021/acs.jctc.5b00707 · DOI
  54. 2019, Dna-nanoscaffold-assisted selection of femtomolar bivalent human alpha-thrombin aptamers with potent anticoagulant activity, ChemBioChem, 20, 2494, 10.1002/cbic.201900265 · DOI
  55. J. Zrimec , F. Buric , M. Kokina , V. Garcia , and A. Zelezniak . Learning the regulatory code of gene expression. Frontiers in Molecular Biosciences, 8, 2021. · DOI

Metadata

Authors
Di Gioacchino, A., Procyk, J., Molari, M., Schreck, J. S., Zhou, Y., Liu, Y., Monasson, R., Cocco, S., & Šulc, P.
Affiliations
  • Arizona State University (US)
  • SIB Swiss Institute of Bioinformatics (CH)
  • NSF National Center for Atmospheric Research (US)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Šulc, Petr
Venue
PLoS Computational Biology
Publisher
openRxiv
Published
2022-03-14
Volume
18
Issue
9
Pages
e1010561-e1010561
ISSN
1553-734X (ISSN-L)
OpenAlex
W4297990198
Cited by
45
References
1
Citations by year
2026: 15 · 2025: 13 · 2024: 7 · 2023: 8 · 2022: 2
FWCI
2.45
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • PLoS Computational Biology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Science Foundation (TG-BIO210009, 2155095)
  • Arizona State University
  • European Commission (101026293, HORIZON2020)
  • Agence Nationale de la Recherche (ANR-17-CE30-0021, RBMPro CE30-0021-01 and ANR-19 Decrypted CE30-0021-01, ANR-19-CE30-0021)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Physical Sciences › Mathematics › Theoretical Computer Science › DNA and Biological Computing
Keywords
aptamer design, SELEX, restricted Boltzmann machine, thrombin-binding aptamer, interpretability, generative models, disruptive mutations, gel shift assay
MeSH terms
Machine Learning, Thrombin, Neural Networks, Computer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review